Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
- PMID: 28935236
- PMCID: PMC5912669
- DOI: 10.1016/j.jinf.2017.09.010
Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies
Abstract
Objectives: Summary evidence of influenza vaccine effectiveness (IVE) against hospitalized influenza is lacking. We conducted a meta-analysis of studies reporting IVE against laboratory-confirmed hospitalized influenza among adults.
Methods: We searched Pubmed (January 2009 to November 2016) for studies that used test-negative design (TND) to enrol patients hospitalized with influenza-associated conditions. Two independent authors selected relevant articles. We calculated pooled IVE against any and (sub)type specific influenza among all adults, and stratified by age group (18-64 and 65 years and above) using random-effects models.
Results: We identified 3411 publications and 30 met our inclusion criteria. Between 2010-11 and 2014-15, the pooled seasonal IVE was 41% (95%CI:34;48) for any influenza (51% (95%CI:44;58) among people aged 18-64y and 37% (95%CI:30;44) among ≥65 years). IVE was 48% (95%CI:37;59),37% (95%CI:24;50) and 38% (95%CI:23;53) against influenza A(H1N1)pdm09, A(H3N2) and B, respectively. Among persons aged ≥65 year, IVE against A(H3N2) was 43% (95%CI:33;53) in seasons when circulating and vaccine strains were antigenically similar and 14% (95%CI:-3;30) when A(H3N2) variant viruses predominated.
Conclusions: Influenza vaccines provided moderate protection against influenza-associated hospitalizations among adults. They seemed to provide low protection among elderly in seasons where vaccine and circulating A(H3N2) strains were antigenically variant.
Keywords: Adults; Hospitalization; Influenza; Meta-analysis; Systematic review; Vaccine effectiveness.
Copyright © 2017 The British Infection Association. All rights reserved.
Conflict of interest statement
All authors declare no competing interests.
Figures
Similar articles
-
Real-world effectiveness of seasonal influenza vaccination and age as effect modifier: A systematic review, meta-analysis and meta-regression of test-negative design studies.Vaccine. 2024 Mar 19;42(8):1883-1891. doi: 10.1016/j.vaccine.2024.02.059. Epub 2024 Feb 28. Vaccine. 2024. PMID: 38423813 Review.
-
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine.Influenza Other Respir Viruses. 2020 May;14(3):302-310. doi: 10.1111/irv.12714. Epub 2020 Feb 5. Influenza Other Respir Viruses. 2020. PMID: 32022450 Free PMC article.
-
Effectiveness of Influenza Vaccination in Preventing Hospitalization Due to Influenza in Children: A Systematic Review and Meta-analysis.Clin Infect Dis. 2021 Nov 2;73(9):1722-1732. doi: 10.1093/cid/ciab270. Clin Infect Dis. 2021. PMID: 33772586
-
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic.Vaccine. 2021 Feb 22;39(8):1225-1240. doi: 10.1016/j.vaccine.2021.01.032. Epub 2021 Jan 22. Vaccine. 2021. PMID: 33494964 Review.
-
Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy.Expert Rev Vaccines. 2019 Nov;18(11):1201-1209. doi: 10.1080/14760584.2019.1688151. Epub 2019 Nov 12. Expert Rev Vaccines. 2019. PMID: 31674847
Cited by
-
Seasonal influenza vaccines: Variability of immune responses to B lineage viruses.Hum Vaccin Immunother. 2024 Dec 31;20(1):2421096. doi: 10.1080/21645515.2024.2421096. Epub 2024 Nov 17. Hum Vaccin Immunother. 2024. PMID: 39552079 Free PMC article. Review.
-
Uptake and correlates of influenza vaccine among older adults residing in rural regions of south China: a cross-sectional study.Front Public Health. 2024 Oct 11;12:1383293. doi: 10.3389/fpubh.2024.1383293. eCollection 2024. Front Public Health. 2024. PMID: 39463901 Free PMC article.
-
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.JAMA. 2024 Oct 11:e2421060. doi: 10.1001/jama.2024.21060. Online ahead of print. JAMA. 2024. PMID: 39392741
-
A Call for Adopting High-Dose Influenza Vaccines for Adults Aged 65 and Above in Gulf Cooperation Council (GCC) Countries.J Epidemiol Glob Health. 2024 Sep;14(3):524-528. doi: 10.1007/s44197-024-00292-8. Epub 2024 Sep 10. J Epidemiol Glob Health. 2024. PMID: 39256316 Free PMC article. Review.
-
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trial.Nat Med. 2024 Nov;30(11):3142-3149. doi: 10.1038/s41591-024-03202-4. Epub 2024 Aug 30. Nat Med. 2024. PMID: 39215149 Clinical Trial.
References
-
- World Health Organization. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec. 2005;80(33):279–87. - PubMed
-
- WHO. [Accessed 27 December 2012];WHO | influenza (seasonal) [Internet] 2012 Available from: http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
-
- Murata Y, Walsh EE, Falsey AR. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis. 2007;195(7):1029–37. - PubMed
-
- Kuiken T, Riteau B, Fouchier RAM, Rimmelzwaan GF. Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol. 2012;2(3):276–86. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
